Team (TISI) Proxy filing summary
Event summary combining transcript, slides, and related documents.
Proxy filing summary
24 Mar, 2026Executive summary
The annual meeting will be held on May 20, 2026, with shareholders voting on five key proposals, including director elections, executive compensation, auditor ratification, a warrant share issuance, and an equity plan amendment.
Shareholders of record as of April 1, 2026, are entitled to vote, with multiple voting methods available, including online, phone, and mail.
The Board recommends voting in favor of all proposals and emphasizes the importance of shareholder participation.
Voting matters and shareholder proposals
Proposal One: Election of three Class I directors for a three-year term.
Proposal Two: Advisory vote on named executive officer compensation (say-on-pay).
Proposal Three: Ratification of KPMG LLP as independent auditor for 2026.
Proposal Four: Approval of Stellex Warrant Shares Issuance Proposal, enabling issuance of shares underlying warrants issued to Stellex.
Proposal Five: Approval of Amendment No. 1 to the 2018 Equity Incentive Plan, increasing shares available for issuance by 250,000.
Shareholder proposals for the next annual meeting must comply with SEC rules and company bylaws.
Board of directors and corporate governance
The Board consists of eight directors divided into three classes, with a majority being independent under NYSE standards.
Board committees include Audit, Compensation, Corporate Governance and Nominating, and Executive Committees, all chaired by independent directors.
The Board regularly evaluates its leadership structure and succession planning, with a Lead Independent Director, non-executive Chairman, and CEO.
Share ownership guidelines and anti-hedging/pledging policies are in place for directors and executives.
Annual self-evaluations are conducted for the Board and its committees.
Latest events from Team
- Revenue, operating income, and adjusted EBITDA rose, margins improved, and debt was reduced.TISI
Q4 202513 Mar 2026 - Margins and cash flow improved in Q2 2024, with full-year growth and guidance reaffirmed.TISI
Q2 20242 Feb 2026 - Q3 2024 revenue and margins improved, but guidance was lowered amid ongoing liquidity and NYSE risks.TISI
Q3 202415 Jan 2026 - Margins and EBITDA improved in 2024, with refinancing extending debt maturities to 2030.TISI
Q4 202426 Dec 2025 - Registering 1.45M shares for resale post-$75M private placement, supporting recapitalization.TISI
Registration Filing16 Dec 2025 - Key votes include director elections, auditor ratification, and a charter amendment on director removal.TISI
Proxy Filing2 Dec 2025 - Annual meeting covers director elections, pay, auditor ratification, and governance updates.TISI
Proxy Filing2 Dec 2025 - Flat Q1 revenue, $29.7M net loss, and refinancing set up at least 15% EBITDA growth for 2025.TISI
Q1 202525 Nov 2025 - Q2 revenue rose 8.5% to $248.0M, Adjusted EBITDA up 12.4%, with margin gains and transformation underway.TISI
Q2 202523 Nov 2025